v3.26.1
Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($)
$ / shares in Thousands, $ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Cash and cash equivalent $ 555,215 $ 621,093
Restricted cash and cash equivalents 89,965 146,314
Loans, interest and fees receivable, at fair value 6,658,748 6,647,882
Allowance for credit losses 3,700 4,100
Deferred revenue 18,200 20,100
Notes payable, at face value $ 5,578,882 $ 5,818,761
Common stock, par value (in dollars per share) $ 0 $ 0
Common stock, authorized (in shares) 150,000,000 150,000,000
Common stock, issued (in shares) 15,170,081 14,922,462
Common stock, outstanding (in shares) 15,170,081 14,922,462
Series A Preferred Stock [Member]    
Preferred stock, no par value (in dollars per share) $ 0 $ 0
Preferred stock, shares authorized (in shares) 10,000,000 10,000,000
Preferred stock, shares issued (in shares) 400,000 400,000
Preferred stock, shares outstanding (in shares) 400,000 400,000
Preferred stock, liquidation preference $ 40,000 $ 40,000
Series B Preferred Stock [Member]    
Preferred stock, no par value (in dollars per share) $ 0 $ 0
Preferred stock, shares issued (in shares) 3,584,646 3,584,131
Preferred stock, shares outstanding (in shares) 3,584,646 3,584,131
Preferred stock, liquidation preference $ 89,600 $ 89,600
Variable Interest Entity, Primary Beneficiary [Member]    
Cash and cash equivalent 225,800 209,600
Restricted cash and cash equivalents 51,200 117,600
Loans, interest and fees receivable, at fair value 6,466,100 6,522,900
Notes payable, at face value $ 5,554,000 $ 5,739,100